Menopausal Hormone Therapy And Left Ventricular Function

Overview

About this study

The purpose of this study is to compare left ventricular stroke volume and heart rate responses to bursts of SNA between PMF using, and not using, MHT.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • 45-70 years of age.

Exclusion Criteria:

  • Male sex

  • Females between STRAW+10 stages -5 and 0.

  • PMF in STRAW+10 stage +2.

  • Females who entered menopause due to a surgical procedure or in response to pharmacotherapy (e.g., gonadotrophin releasing hormone agonists or chemotherapy)

  • Heart disease such as hypertropic cardiomyopathy, congenital abnormalities, heart failure, and coronary artery disease.

  • Medications that impact the central nervous system such as selective serotonin reuptake inhibitors, anxiolytics, sedatives, anticholinergic agents, dopamine, amphetamines, or wake-promoting agents (e.g., modafinil)

  • Cardiovascular medications is also an exclusion criterion which includes those acting on the renin-angiotensin-aldosterone axis, adrenergic receptor antagonists, diuretics, nitrates, and calcium channel antagonists.

  • Pregnancy

  • COPD

  • Diabetes

  • CKD

  • Raynaud’s phenomenon

  • Sleep disorders

  • Shift workers

  • BMI ≥40.0kg/m2

  • Use of nicotine-containing products within the two years preceding study visits

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 6/20/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Joshua Bock

Open for enrollment

Contact information:

Joshua Bock

(507) 422-0768

bock.joshua@mayo.edu

More information

Publications

Publications are currently not available